Bizarre Patents
A simulation environment for the sport of boxing utilizing a robotic machine interface system which carries a person.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8063214 | Polymorphic forms of tadalafil A process for preparing crystalline Form A of tadalafil (I), comprising crystallization from a solution of tadalafil in a solvent comprising a C3-C7 ester, a ketone, dimethylformamide, dimethylsulfoxide, ethanol, acetonitrile, a chlorinated hyd... | 11/22/2011 |
| 7879902 | Pyrrole derivatives, intermediates therefor, preparation and therapeutic use thereof The invention concerns compounds of formula (I): Wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined herein. The in... | 02/01/2011 |
| 7863290 | Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics The invention relates to compounds having general formula (I), wherein R is as defined herein. The invention also relates to acid addition salt, a hydrate or a solvate of compounds of formula (I). The invention further relate... | 01/04/2011 |
| 7589120 | N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application The invention relates to compounds of formula (I): Wherein X, R1, R2, R3 and R4 are as described herein. The invention also relates to a method for preparing the aforementioned co... | 09/15/2009 |
| 7468368 | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I) in which: n is 1 or 2; p is 1 or 2; R1 | 12/23/2008 |
| 7396958 | Sulphonamide derivatives, their preparation and their therapeutic application Disclosed are compounds having the general formula (I) as defined herein, the preparation thereof, and the use thereof for the prophylaxis or treatment of any disease involving a dysfunction associated with the orexin 2 rec... | 07/08/2008 |
| 7045649 | C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals Embodiments of the invention relate to C2-substituted indan-1-ols and to their physiologically acceptable salts and physiologically functional derivatives. Compounds of embodiments of the invention may include compounds of formula I | 05/16/2006 |
| 7041668 | Substituted benzimidazole compounds and their use for the treatment of cancer The present invention discloses and claims benzimidazole compounds of formula (I): in which A is aryl or heteroaryl; R1 is selected from optionally substituted alkyl, alkoxy, aryl or heteroaryl, NH-lower alky... | 05/09/2006 |
| 7019110 | Streptogramin derivatives, preparation method and compositions containing same Group B streptogramin derivatives of general formula (I) are disclosed: wherein Ra, Rb, Rc, Rd, R1, R2 and Y are as defined in the description, including preparation methods and compositions contai... | 03/28/2006 |
| 6946269 | Alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid of use as intermediates The invention relates to lower-alkyl esters of 3-(3,4-dihalophenyl)-2,6-dioxopiperidine-3-propionic acid derivatives, and to processes for preparing the same. ... | 09/20/2005 |
| 6933320 | Combination comprising combretastatin and anticancer agents An antitumor combination comprising a stilbene derivative and an anticancer compound selected from the group consisting of taxanes, alkylating agents, antimetabolites, vinca alkaloids, platinum compounds, epidophylloptoxins, and antibiotics as the active ingredients... | 08/23/2005 |
| 6930103 | Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases The invention describes and claims the use of vasopeptidase inhibitors of formula (I) for the treatment of nephropathy in diabetic or non-diabetic patients, including diabetic or non-diabetic nephropathy, glomeruloneph... | 08/16/2005 |
| 6323195 | Galanthamine derivatives as acetylcholinesterase inhibitors This application relates to compounds of the formula ##STR1## wherein R1 is hydrogen, (C1 -C12 alkylcarbonyl, (C1 -C12)alkoxycarbonyl, mono(C1 -C12)alkylaminocarbonyl, or di(C | 11/27/2001 |
| 6022880 | Substituted pyridylamino indoles There are disclosed various compounds of the formula below, ##STR1## where R, R1, W, X, Y and Z are as defined in the specification; which are useful for alleviating various memory dysfunctions such as Alzheimer's disease, as modulators of... | 02/08/2000 |
